Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study

BACKGROUND: The safety of COVID-19 vaccines has been clarified in clinical trials; however, some immunocompromised patients, such as myasthenia gravis (MG) patients, are still hesitant to receive vaccines. Whether COVID-19 vaccination increases the risk of disease worsening in these patients remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Zhe, Huan, Xiao, Su, Yue, Tang, Yong-Lan, Meng, Dong-Dong, Ren, Da-Lin, Li, Chun-Hong, Hao, Si-Jia, Zhao, Chong-Bo, Luo, Su-Shan, Li, Zhu-Yi, Chang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200982/
https://www.ncbi.nlm.nih.gov/pubmed/37223097
http://dx.doi.org/10.3389/fimmu.2023.1141983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200982/
https://www.ncbi.nlm.nih.gov/pubmed/37223097
http://dx.doi.org/10.3389/fimmu.2023.1141983

Ejemplares similares